全文获取类型
收费全文 | 99353篇 |
免费 | 8769篇 |
国内免费 | 5898篇 |
专业分类
耳鼻咽喉 | 1128篇 |
儿科学 | 1185篇 |
妇产科学 | 630篇 |
基础医学 | 8558篇 |
口腔科学 | 1612篇 |
临床医学 | 11086篇 |
内科学 | 10853篇 |
皮肤病学 | 1084篇 |
神经病学 | 3376篇 |
特种医学 | 4584篇 |
外国民族医学 | 8篇 |
外科学 | 11954篇 |
综合类 | 22838篇 |
现状与发展 | 21篇 |
一般理论 | 3篇 |
预防医学 | 8955篇 |
眼科学 | 1665篇 |
药学 | 10835篇 |
111篇 | |
中国医学 | 7430篇 |
肿瘤学 | 6104篇 |
出版年
2024年 | 322篇 |
2023年 | 1131篇 |
2022年 | 2791篇 |
2021年 | 3799篇 |
2020年 | 3180篇 |
2019年 | 2256篇 |
2018年 | 2435篇 |
2017年 | 2767篇 |
2016年 | 2536篇 |
2015年 | 4136篇 |
2014年 | 5445篇 |
2013年 | 6323篇 |
2012年 | 9011篇 |
2011年 | 9319篇 |
2010年 | 7674篇 |
2009年 | 6800篇 |
2008年 | 7275篇 |
2007年 | 7137篇 |
2006年 | 6472篇 |
2005年 | 5237篇 |
2004年 | 3995篇 |
2003年 | 3685篇 |
2002年 | 3114篇 |
2001年 | 2338篇 |
2000年 | 1573篇 |
1999年 | 844篇 |
1998年 | 414篇 |
1997年 | 429篇 |
1996年 | 316篇 |
1995年 | 238篇 |
1994年 | 191篇 |
1993年 | 115篇 |
1992年 | 110篇 |
1991年 | 118篇 |
1990年 | 75篇 |
1989年 | 64篇 |
1988年 | 54篇 |
1987年 | 56篇 |
1986年 | 44篇 |
1985年 | 41篇 |
1984年 | 13篇 |
1983年 | 18篇 |
1982年 | 16篇 |
1981年 | 8篇 |
1980年 | 8篇 |
1979年 | 13篇 |
1978年 | 11篇 |
1975年 | 8篇 |
1974年 | 8篇 |
1973年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
Xue Yao Yan Zhang Jian Hao Hui-Quan Duan Chen-Xi Zhao Chao Sun Bo Li Bao-You Fan Xu Wang Wen-Xiang Li Xuan-Hao Fu Yong Hu Chang Liu Xiao-Hong Kong Shi-Qing Feng 《中国神经再生研究》2019,(3)
Ferroptosis is an iron-dependent novel cell death pathway. Deferoxamine, a ferroptosis inhibitor, has been reported to promote spinal cord injury repair. It has yet to be clarified whether ferroptosis inhibition represents the mechanism of action of Deferoxamine on spinal cord injury recovery. A rat model of Deferoxamine at thoracic 10 segment was established using a modified Allen's method. Ninety 8-week-old female Wistar rats were used. Rats in the Deferoxamine group were intraperitoneally injected with 100 mg/kg Deferoxamine 30 minutes before injury. Simultaneously, the Sham and Deferoxamine groups served as controls. Drug administration was conducted for 7 consecutive days. The results were as follows:(1) Electron microscopy revealed shrunken mitochondria in the spinal cord injury group.(2) The Basso, Beattie and Bresnahan locomotor rating score showed that recovery of the hindlimb was remarkably better in the Deferoxamine group than in the spinal cord injury group.(3) The iron concentration was lower in the Deferoxamine group than in the spinal cord injury group after injury.(4) Western blot assay revealed that, compared with the spinal cord injury group, GPX4, xCT, and glutathione expression was markedly increased in the Deferoxamine group.(5) Real-time polymerase chain reaction revealed that, compared with the Deferoxamine group, mRNA levels of ferroptosis-related genes Acyl-CoA synthetase family member 2(ACSF2) and iron-responsive element-binding protein 2(IREB2) were up-regulated in the Deferoxamine group.(6) Deferoxamine increased survival of neurons and inhibited gliosis. These findings confirm that Deferoxamine can repair spinal cord injury by inhibiting ferroptosis. Targeting ferroptosis is therefore a promising therapeutic approach for spinal cord injury. 相似文献
12.
13.
Yong Luo Yang Zou Li-ping Li Zhao-zhen Wang Li-qun Wang Zi-yu Zhang 《Gynecological endocrinology》2020,36(10):895-901
AbstractOxidative stress (OS) has been proposed to play a role in the development of EMs. Peroxiredoxins are a family of antioxidant proteins that exhibit peroxidase activity in a thioredoxin-dependent manner, protecting cells against OS. The Western blotting results showed that the relative expression of PRDX4 was significantly increased in ectopic endometria compared with the normal endometria of EMs-free (p?<?.05). The H2O2 concentration was also significantly higher in the ectopic endometrium. PRDX4 siRNA was transfected into primary ectopic endometrial stromal cells (EESCs). The viability of the transfected EESCs was measured by CCK-8 assay, and the results showed significantly decreased cell viability. Furthermore, the apoptosis rate and ROS generation in flow cytometry assays were significantly increased after the knockdown of PRDX4 expression (p?<?.05). Scratch assays and transwell assays revealed that decreased expression of PRDX4 mediated by siRNA inhibited EESC migration and invasion. In conclusion, these findings indicate the potential role of PRDX4 in the development of EMs and PRDX4 as a possible therapeutic target for EMs treatment. 相似文献
14.
线粒体脑肌病属于罕见性母系遗传病,本文回顾性分析了1家4例高乳酸血症-卒中样发作综合征(MELAS)型线粒体脑肌病患者,其主要表现为卒中样发作、头痛、癫痫、高乳酸血症、肌肉不耐受疲劳、高级智能下降、听力下降和身材矮小等,结合特征性影像学变化、基因检测及肌肉活检明确诊断,并结合文献对只有女儿能将其线粒体DNA(mt-DNA)传递给下一代的母系遗传MELAS型线粒体脑肌病临床特点进行了总结分析,旨在帮助临床认识此病,进一步提高MELAS型线粒体脑肌病的临床诊断率。 相似文献
16.
17.
目的分析胃造口周围皮下感染患者的病原菌分布及耐药菌,进行相应的护理预防措施,降低胃造口周围皮下感染率。方法选择2010年5月-2015年5月在医院行胃造口术发生周围皮下感染的300例患者,采用法国生物梅里埃公司VITEK-2Compact细菌鉴定进行细菌鉴定,药物敏感试验采用K-B法;分析患者的病原菌分布和耐药性,采用SPSS16.0统计软件对数据进行统计分析。结果共检出病原菌300株,其中金黄色葡萄球菌81株占27.0%,溶血性链球菌60株占20.0%,革兰阴性菌中大肠埃希菌对氨苄西林、头孢唑林的耐药率50.0%,肺炎克雷伯菌对氨苄西林、头孢唑林的耐药率70.0,铜绿假单胞菌对氨苄西林以及头孢唑林的耐药率60.0%;革兰阳性菌中葡萄球菌属对青霉素、红霉素的耐药率均最高,70.0%,溶血性链球菌对红霉素、阿奇霉素的耐药率均最高,均为75.0%,肠球菌属对青霉素、氯霉素、阿奇霉素以及万古霉素的耐药率均较低,尤其是阿奇霉素,耐药率为0。结论金黄色葡萄球菌与溶血性链球菌检出率最高,需根据病原菌的药敏,合理应用抗菌药物,对感染患者进行针对性的护理干预,能够有效降低感染状况的发生。 相似文献
18.
20.
Membrane trafficking processes are presumably vital for axonal regeneration after injury, but mechanistic understanding in this regard has been sparse. A recent loss-of-function screen had been carried out for factors important for axonal regeneration by cultured cortical neurons and the results suggested that the activity of a number of Rab GTPases might act to restrict axonal regeneration. A loss of Rab27b, in particular, is shown to enhance axonal regeneration in vitro, as well as in C. elegans and mouse central nervous system injury models in vivo. Possible mechanisms underlying this new finding, which has important academic and translational implication, are discussed. 相似文献